激情综合色综合久久综合 I 国产欧美日韩一区二区三区 I 精品日本一区二区三区在线观看 I 日本公妇乱偷中文字幕 I 亚洲国产精品一区二区久久hs I 日本人做爰大片免费观看 I 精品国产精品久久一区免费式 I 1314成人免费看A片 I 男人和女人免费观看电视连续剧 I 手机福利视频 I melody在线高清免费观看 I 台湾成人娱乐网 I 韩国三级在线 I 老司机免费视频 I www四虎 I 97国产在线 I 日本动漫艳母 I 欧美日韩三区

Founded in 2004, Shandong Keyuan Pharmaceutical Co., Ltd. is the core member of Linuo Healthcare Industry. It is a high-tech company dedicated to the R&D, manufacture and sales of APIs. Its portfolio covers anti-diabetic agents, cardiovascular agents and anesthetics. Keyuan has established strategic partnership with many renowned international companies.  
The company consistently upholds the entrepreneurship and practical working style. With the accumulative industrial strength and the technology-guided and people-oriented business principle, the company has gradually become the backbone of Shandong synthetic API industry.  
The company produces gliclazide, metformin hydrochloride, isosorbide mononitrate, isosorbide dinitrate, isoclurance, ropivacaine hydrochloride and clarithromycin lactobionate.
Main accreditations: gliclazide, isosorbide monoitrate mixed powder and other products have obtained the accreditation of CEP. PLNS has obtained the accreditation of FDA.
In March 2016, Keyuan was listed on NEEQ. NEEQ varies the choice of investment and expands the withdrawal of venture investment institutions. Being listed on NEEQ provides more financing channels for the company, expanding the financing platform, and make the financing more flexible, which lays an increasingly solid foundation for the further development of the company and strengthens its international competitiveness. Keyuan will make itself a larger and stronger company with the help of the capital market.
Keyuan upholds the motto of Serving the country with industry and striving for excellence and is devoted to establishing the largest production base of anti-diabetic agents, cardiovascular agents and anesthetics for the benefit of the patients.